Mingchen Health Co.,Ltd. (SHE:002919)
China · Delayed Price · Currency is CNY 19.64
-0.27 (-1.36%)
Jun 18, 2026, 10:05 AM CST
Mingchen Health Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 1,556 | 1,500 | 1,376 | 1,634 | 944.04 | 743.07 |
Other Revenue | 14.05 | 14.05 | 4.29 | 3.38 | 1.37 | 1.08 |
| 1,571 | 1,514 | 1,380 | 1,638 | 945.4 | 744.15 | |
Revenue Growth (YoY) | 13.82% | 9.72% | -15.71% | 73.21% | 27.05% | 9.34% |
Cost of Revenue | 713.77 | 702.4 | 665.8 | 660.08 | 457.7 | 378.28 |
Gross Profit | 856.77 | 812.05 | 714.45 | 977.49 | 487.71 | 365.87 |
Selling, General & Admin | 795.01 | 735.45 | 548.57 | 777.45 | 400.32 | 152.59 |
Research & Development | 58.82 | 57.42 | 67.38 | 106.77 | 110.26 | 98.51 |
Other Operating Expenses | 5.09 | 4.7 | 5.15 | 4.71 | 5.36 | 6.57 |
Operating Expenses | 886.86 | 833.02 | 670.8 | 903.25 | 507.77 | 264.18 |
Operating Income | -30.09 | -20.97 | 43.65 | 74.24 | -20.06 | 101.69 |
Interest Expense | -2.46 | -1.8 | -1.58 | -3.68 | -1.95 | -1.71 |
Interest & Investment Income | 0.92 | 1 | 1.2 | 1.15 | 6.76 | 25.21 |
Currency Exchange Gain (Loss) | -0.01 | -0.01 | 0.98 | 1.76 | 0.99 | - |
Other Non Operating Income (Expenses) | -0.9 | -0.49 | -0.51 | 0.69 | -1.28 | -2.5 |
EBT Excluding Unusual Items | -32.54 | -22.28 | 43.74 | 74.16 | -15.54 | 122.69 |
Impairment of Goodwill | - | - | - | -23.54 | - | - |
Gain (Loss) on Sale of Investments | 102.72 | 102.68 | 0.38 | - | -0 | 0 |
Gain (Loss) on Sale of Assets | -0.3 | -0.51 | 4.38 | 2.07 | 0.1 | -0.01 |
Asset Writedown | -26.76 | -26.76 | -17.37 | -0.02 | -0.05 | -0.12 |
Other Unusual Items | 0.16 | 0.49 | -3.65 | 3.97 | 30.75 | 4.94 |
Pretax Income | 43.3 | 53.63 | 27.48 | 56.63 | 15.25 | 127.51 |
Income Tax Expense | 19.99 | 25.83 | -19.24 | -13.73 | -10.14 | -5.99 |
Earnings From Continuing Operations | 23.31 | 27.8 | 46.72 | 70.36 | 25.39 | 133.49 |
Minority Interest in Earnings | 1.46 | 0.51 | 0 | - | - | - |
Net Income | 24.77 | 28.31 | 46.72 | 70.36 | 25.39 | 133.49 |
Net Income to Common | 24.77 | 28.31 | 46.72 | 70.36 | 25.39 | 133.49 |
Net Income Growth | 69.17% | -39.41% | -33.60% | 177.15% | -80.98% | 30.57% |
Shares Outstanding (Basic) | 267 | 267 | 267 | 271 | 277 | 267 |
Shares Outstanding (Diluted) | 267 | 267 | 267 | 271 | 277 | 267 |
Shares Change (YoY) | -0.26% | 0.02% | -1.52% | -2.25% | 3.70% | 0.43% |
EPS (Basic) | 0.09 | 0.11 | 0.18 | 0.26 | 0.09 | 0.50 |
EPS (Diluted) | 0.09 | 0.11 | 0.18 | 0.26 | 0.09 | 0.50 |
EPS Growth | 69.61% | -39.42% | -32.58% | 183.53% | -81.66% | 30.00% |
Free Cash Flow | 66.48 | 1.14 | 116.66 | 56.61 | -77.28 | 64.4 |
Free Cash Flow Per Share | 0.25 | 0.00 | 0.44 | 0.21 | -0.28 | 0.24 |
Dividend Per Share | 0.050 | 0.050 | 0.050 | 0.125 | - | 0.137 |
Dividend Growth | - | - | -60.00% | - | - | 17.64% |
Gross Margin | 54.55% | 53.62% | 51.76% | 59.69% | 51.59% | 49.17% |
Operating Margin | -1.92% | -1.39% | 3.16% | 4.53% | -2.12% | 13.66% |
Profit Margin | 1.58% | 1.87% | 3.38% | 4.30% | 2.69% | 17.94% |
Free Cash Flow Margin | 4.23% | 0.07% | 8.45% | 3.46% | -8.18% | 8.65% |
EBITDA | -24.12 | -10.46 | 72.33 | 219.53 | 17.11 | 119.69 |
EBITDA Margin | -1.54% | -0.69% | 5.24% | 13.41% | 1.81% | 16.08% |
D&A For EBITDA | 5.97 | 10.51 | 28.68 | 145.29 | 37.16 | 18.01 |
EBIT | -30.09 | -20.97 | 43.65 | 74.24 | -20.06 | 101.69 |
EBIT Margin | -1.92% | -1.39% | 3.16% | 4.53% | -2.12% | 13.66% |
Effective Tax Rate | 46.17% | 48.16% | - | - | - | - |
Revenue as Reported | 1,571 | 1,514 | 1,380 | 1,638 | 945.4 | 744.15 |
Advertising Expenses | - | 55.06 | 8.32 | 6.73 | 4.16 | 5.61 |